Psychoactive fungi

Momentum Builds Behind the Push for Psilocybin Decriminalization

Retrieved on: 
Friday, May 29, 2020

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Key Points: 
  • Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.
  • According to the study , this provides an understanding of why psilocybin is showing considerable promise as a therapeutic intervention for neuropsychiatric disorders including depression, anxiety, and addiction.
  • CBD products have become more popular and well-known because of their lack of psychoactive effects many associate with cannabis.
  • Numinus believes the societal costs of mental illness, addictions, trauma and unmet human potential are much too high.

Momentum Builds Behind the Push for Psilocybin Decriminalization

Retrieved on: 
Friday, May 29, 2020

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Key Points: 
  • Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.
  • According to the study , this provides an understanding of why psilocybin is showing considerable promise as a therapeutic intervention for neuropsychiatric disorders including depression, anxiety, and addiction.
  • CBD products have become more popular and well-known because of their lack of psychoactive effects many associate with cannabis.
  • Numinus believes the societal costs of mental illness, addictions, trauma and unmet human potential are much too high.

/R E P E A T -- New Wave Holdings Corp. Provides Update on Jamaican Mushroom Cultivation and Extraction Facilities/

Retrieved on: 
Wednesday, May 20, 2020

This includes its cultivation facility, "High Grade Farms" and its extraction facility, "Medz Up."

Key Points: 
  • This includes its cultivation facility, "High Grade Farms" and its extraction facility, "Medz Up."
  • The nearly completed cultivation facility is modular and built using modified, forty-foot containers for rapid production of psilocybin mushrooms.
  • Customized fruiting racks and inoculation and spore collection equipment for cultivation of psilocybin will be set up in phase one.
  • At this time, the Medz Up extraction facility will also be modified for psilocybin mushroom extraction to create derivative products.

New Wave Holdings Corp. Provides Update on Jamaican Mushroom Cultivation and Extraction Facilities

Retrieved on: 
Wednesday, May 20, 2020

TORONTO, May 19, 2020 /PRNewswire/ -NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") ( CSE: SPOR ) ( FWB: 0XM2 ), ( OTC:TRMND ), is pleased to provide an update on the status of its psychedelic and functional mushroom cultivation and extraction facilities in Jamaica.

Key Points: 
  • TORONTO, May 19, 2020 /PRNewswire/ -NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") ( CSE: SPOR ) ( FWB: 0XM2 ), ( OTC:TRMND ), is pleased to provide an update on the status of its psychedelic and functional mushroom cultivation and extraction facilities in Jamaica.
  • The nearly completed cultivation facility is modular and built using modified, forty-foot containers for rapid production of psilocybin mushrooms.
  • Customized fruiting racks and inoculation and spore collection equipment for cultivation of psilocybin will be set up in phase one.
  • At this time, the Medz Up extraction facility will also be modified for psilocybin mushroom extraction to create derivative products.

Psychedelic Products Gain Traction for Medicinal Purposes

Retrieved on: 
Friday, May 1, 2020

The naturally occurring psychedelic prodrug compound psilocybin, which is produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Key Points: 
  • The naturally occurring psychedelic prodrug compound psilocybin, which is produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.
  • Psychedelic products may take on a similar path to the legalization of cannabis in recent times, and finally breaking free of their stigmas.
  • For example, this March,New York Citywitnessed the debut of its first legal, upscale guided psychedelic therapy center.
  • MindMed is the leading psychedelic pharmaceutical company and the Liechti Laboratory is the leading research center focused on the pharmacology of psychedelic substances.

Psychedelic Products Gain Traction for Medicinal Purposes

Retrieved on: 
Friday, May 1, 2020

The naturally occurring psychedelic prodrug compound psilocybin, which is produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Key Points: 
  • The naturally occurring psychedelic prodrug compound psilocybin, which is produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.
  • Psychedelic products may take on a similar path to the legalization of cannabis in recent times, and finally breaking free of their stigmas.
  • For example, this March,New York Citywitnessed the debut of its first legal, upscale guided psychedelic therapy center.
  • MindMed is the leading psychedelic pharmaceutical company and the Liechti Laboratory is the leading research center focused on the pharmacology of psychedelic substances.

REPEAT - Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami

Retrieved on: 
Wednesday, April 22, 2020

The Company is pleased to announce that its research partner and lead investigator, Dr. Michael Hoffer, has secured a sustainable supply of psilocybin under a DEA schedule I license, which will be used for ongoing psilocybin-based therapeutics studies.

Key Points: 
  • The Company is pleased to announce that its research partner and lead investigator, Dr. Michael Hoffer, has secured a sustainable supply of psilocybin under a DEA schedule I license, which will be used for ongoing psilocybin-based therapeutics studies.
  • The psilocybin is to be provided by the same organization that has supplied both Johns Hopkins University and Yale University throughout their respective psilocybin research studies and trials.
  • University of Miamis Miller School of Medicines medical campus includes more than 500,000square feet of research space, as well as a state-of-the-art, 1.8-million-square-foot, lab-ready research park.
  • Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified.

Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami

Retrieved on: 
Wednesday, April 22, 2020

The Company is pleased to announce that its research partner and lead investigator, Dr. Michael Hoffer, has secured a sustainable supply of psilocybin under a DEA schedule I license, which will be used for ongoing psilocybin-based therapeutics studies.

Key Points: 
  • The Company is pleased to announce that its research partner and lead investigator, Dr. Michael Hoffer, has secured a sustainable supply of psilocybin under a DEA schedule I license, which will be used for ongoing psilocybin-based therapeutics studies.
  • The psilocybin is to be provided by the same organization that has supplied both Johns Hopkins University and Yale University throughout their respective psilocybin research studies and trials.
  • University of Miamis Miller School of Medicines medical campus includes more than 500,000square feet of research space, as well as a state-of-the-art, 1.8-million-square-foot, lab-ready research park.
  • Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified.

Mental Health Comes Face to Face With Psychedelics

Retrieved on: 
Tuesday, April 21, 2020

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Key Points: 
  • Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.
  • Just last year, the Johns Hopkins School of Medicine opened the Center for Psychedelic and Consciousness Research in Baltimore.
  • We were fortunate to watch the cannabis industry grow into a sustainable marketplace for both medicinal and recreational use.
  • The clinic has been licensed by Health Canada to dose eligible patients with psilocybin and is the only clinic inCanadato perform psilocybin doses under Health Canada approval.

Mental Health Comes Face to Face With Psychedelics

Retrieved on: 
Tuesday, April 21, 2020

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Key Points: 
  • Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.
  • Just last year, the Johns Hopkins School of Medicine opened the Center for Psychedelic and Consciousness Research in Baltimore.
  • We were fortunate to watch the cannabis industry grow into a sustainable marketplace for both medicinal and recreational use.
  • The clinic has been licensed by Health Canada to dose eligible patients with psilocybin and is the only clinic inCanadato perform psilocybin doses under Health Canada approval.